Impact of standardization on clinical cell analysis by flow cytometry

Journal of Biological Regulators and Homeostatic Agents

Volumn 18, Issue 3-4, 2004, Pages 305-312

  Keeney, Michael ^a   Barnett, D ^b   Gratama, J W ^c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CD34+ stem cells; CD4+ T cells; Flow cytometry; HLA B27 screening; Leukemia lymphoma immunophenotyping; Standardization

Indexed keywords

CD34 ANTIGEN; CD4 ANTIGEN; HLA B27 ANTIGEN;

ACCREDITATION; ANALYTIC METHOD; ANTIGEN DETECTION; B LYMPHOCYTE; BIOTECHNOLOGY; CELL POPULATION; DIAGNOSTIC VALUE; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOPHENOTYPING; LABORATORY TEST; LEUKEMIA; LYMPHOMA; MEDICAL RESEARCH; PRACTICE GUIDELINE; QUALITY CONTROL; REVIEW; STANDARDIZATION; STEM CELL; T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CYTOLOGY; IMMUNOLOGY; METHODOLOGY; STANDARD;

ANTIGENS, CD34; CD4 LYMPHOCYTE COUNT; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HLA-B27 ANTIGEN; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA;

EID: 17844383935     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Bernard A, Boumsell L. The clusters of differentiation (CD) defined by the First International Workshop on Human Leucocyte Differentiation Antigens. Hum Immunol 1984; 11: 1-10.
2. Gratama JW, Sutherland DR, Keeney M. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. Sem Hematol 2001; 38: 139-47.
3. Lopez-Larrea C, Gonzales-Roces S, Alvarez V. HLA-B27 structure, function, and disease association. Curr Opin Rheumatol 1996; 8: 296-308.
4. National Committee for Clinical Laboratory Standards. Clinical applications of flow cytometry: Quality assurance and immunophenotyping of lymphocytes; approved guidelines. NCCLS document H42-A2 [ISBN 1-56238-000-0]. NCCLS, Wayne, PA, 2004.
5. + T lymphocytes in immunosuppressed individuals. Clin Lab Haematol 1997; 19: 231-41.
6. + T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. MMWR Recomm Rep 2003; 52 (RR-2): 1-13.
7. Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J. Guidelines for flow cytometric immunophenotyping: A report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993; 14: 702-15.
8. National Committee for Clinical Laboratory Standards. Clinical applications of flow cytometry: Immunophenotyping of leukemic cells; approved guidelines. NCCLS document H43-A [ISBN 1-56238-351-5]. NCCLS, Wayne, PA, 1998.
9. Van Bockstaele DR, Deneys V, Philippe J, et al, for the Belgian Association for Cytometry/Belgische Vereniging voor Cytometrie/Association Belge de Cytometrie. Belgian consensus recommendations for flow cytometric immunophenotyping. Acta Clin Belg 1999; 54: 88-98.
10. Rothe G, Schmitz G, for the Working Group on Flow Cytometry and Image Analysis. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia 1996; 10: 877-95.
11. Bené MC, Castoldi G, Knapp W, et al for the European Group for the Immunological Characterization of Leukemias (EGIL). Proposals for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783-6.
12. Website of the Foundation for Immunophenotyping in Hemato-Oncology in The Netherlands (SIHON): http://www.sihon.nl/protocollen.
13. + cell analysis: Technical recommendations for progenitor cell enumeration in leukapheresis from multiple myeloma patients. J Hematother 1995; 4: 21-8.
14. + cell determination by flow cytometry. J Hematother 1996; 5: 213-26.
15. Gutensohn K, Carrero I, Krueger W, Kroeger N, Schafer P, Luedemann K, Kuehnl P. Semi-automated flow cytometric analysis of CD34-expressing hematopoietic cells in peripheral blood progenitor cell apheresis products. Transfusion 1999; 39: 1220-6.
16. + hematopoietic stem and progenitor cells. Curr Prot Cytometry 2003; 6.4.1 - 6.4.25.
17. Levering WHBM, Wind H, Hooijkaas H, Sintnicolaas K, Brando B, Gratama JW. Flow cytometric screening for HLA-B27 on peripheral blood lymphocytes. J Biol Reg Homeost Agents 2003; 17: 241-6.
18. Chen JC, Bigelow N, Davis BH. Proposed flow cytometric reference method for the determination of erythroid F-cell counts. Cytometry 2000; 42: 239-46.
19. International Council for Standardization in Hematology Expert Panel on Cytometry; International Society of Laboratory Hematology Task Force on Platelet Counting. Platelet counting by the RBC/platelet ratio method: A reference method. Am J Clin Pathol 2001; 115: 460-4.
20. Goodfellow KJ, Storie I, Granger V, Whitby L, Antcliffe J, Reilly JT, Barnett D. The United Kingdom National External Quality Assessment Scheme gating and standardization strategy for use in residual WBC counting of WBC-reduced blood components. Transfusion 2002; 42: 738-46.
21. + T-cell enumeration. Cytometry 1997; 30: 157-65.
22. Loken MR, Brosnan JM, Bach BA, Ault KA. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 1990; 11: 453-9.
23. Brando B, Barnett D, Janossy G, et al, for the European Working Group on Clinical Cell Analysis (EWGCCA). Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. Cytometry 2000; 42: 327-46.
24. + T-cell determinations in persons with human immunodeficiency virus infection. MMWR Recomm Rep 1992; 41 (RR-8): 1-17.
25. Mandy FF, Bergeron M, Recktenwald D, Izaguirre C. A simultaneous three-color T cell subsets analysis with single laser flow cytometers using T cell gating protocol. J Immunol Meth 1992; 156: 151-62.
26. Nicholson JKA, Jones BM, Hubbard M. CD4 T-lymphocyte determinations on whole blood specimens using a single-tube three-color assay. Cytometry 1993; 14: 685-9.
27. Bergeron M, Faucher S, Minkus T, et al, and the Participating Flow Cytometry Laboratories of the Canadian Clinical Trials Network for HIV/AIDS Therapies. Impact of unified procedures as implemented in the Canadian quality assurance program for T lymphocyte subset enumeration. Cytometry 1998; 33: 146-55.
28. Nicholson JKA, Hubbard M, Jones BM. Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. Cytometry 1996; 26: 16-21.
29. Centers for Disease Control and Prevention (CDC). 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR Recomm Rep 1997 (RR-2); 46: 1-29.
30. Nicholson J, Kidd P, Mandy F, Livnat D, Kagan J. Three-color supplement to the NIAID DAIDS guideline for flow cytometric immunophenotyping. Cytometry 1996; 26: 227-30.
31. + lymphocyte counts across laboratories: An evaluation of the Ortho Cytoron-Absolute flow cytometry system on normal donors. Cytometry 1995; 22: 200-10.
32. Nicholson JK, Stein D, Mui T, Mack R, Hubbard M, Denny T. Evaluation of a method for counting absolute numbers of cells with a flow cytometer. Clin Diagn Lab Immunol 1997; 4: 309-13.
33. Schlenke P, Frohn C, Klueter H, et al. Evaluation of a flow cytometric method for simultaneous leukocyte phenotyping and quantification by fluorescent microspheres. Cytometry 1998; 33: 310-7.
34. Schnizlein-Bick CT, Spritzler J, Wilkening CL, Nicholson JKA, O'Gorman MRG, Site Investigators, and the NIAID DAIDS New Technologies Evaluation Group. Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Clin Diagn Lab Immunol 2000; 7: 336-43.
35. Reimann KA, O'Gorman MRG, Spritzler J, et al, and the NIAID DAIDS New Technologies Evaluation Group. Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: Evaluation of Beckman Coulter Flow-Count fluorospheres and the tetraONE system. Clin Diagn Lab Immunol 2000; 7: 344-51.
36. Whitby L, Granger V, Storie I, et al. Quality control of CD4+ T-lymphocyte enumeration: Results from the last 9 years of the United Kingdom National External Quality Assessment Scheme for Immune Monitoring (1993-2001). Cytometry 2002; 50: 102-10.
37. Gratama JW, Kraan J, Keeney M, Granger V, Barnett D. Reduction of variation in T-cell subset enumeration among 55 laboratories using single-platform, three or four-color flow cytometry based on CD45 and SSC-based gating of lymphocytes. Cytometry 2002; 50: 92-101.
38. Mandy F, Bergeron M, Houle G, Bradley J, Fahey J. Impact of the international program for Quality Assessment and Standardization for Immunological Measures Relevant to HIV/AIDS: QASI. Cytometry 2002; 50: 111-6.
39. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted PanLeuco-gating for accurate, cost-effective dual-platform CD4+T-cell enumeration. Cytometry 2002; 50: 69-77.
40. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 74: 1905-1914.
41. Siena S, Bregni M, Brando B, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-9.
42. Gratama JW, Sutherland DR, Keeney M, Papa S. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. J Biol Reg Homeostat Agents 2001; 15: 14-22.
43. + cell counts based on the ISHAGE guidelines. Cytometry 1998; 34: 61-70.
44. Allan DS, Keeney M, Howson-Jan K, et al. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 967-72.
45. + stem cell enumeration using stable test material, standard protocols and targeted training. Br J Haematol 2000; 108: 784-92.
46. Gratama JW, Kraan J, Keeney M, Sutherland DR, Granger V, Barnett D. Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study. Cytotherapy 2003; 5: 55-65.
47. + cell enumeration. Cytotherapy 2004; 6: 50-61.
48. Levering WHBM, Wind H, Sintnicolaas K, Hooijkaas H, Gratama JW. Flow cytometric HLA-B27 screening: Crossreactivity patterns of commercially available anti-HLA-B27 monoclonal antibodies with other HLA-B antigens. Cytometry 2003; 54B: 28-38.
49. Levering WHBM, Van den Beemd R, Te Marvelde JG, et al. External quality assessment of flow cytometric HLA-B27 typing. Cytometry 2000; 42: 95-105.
50. Van't Veer MB, Kluin-Nelemans JC, van der Schoot CE, van Putten WL, Adriaansen HJ, van Wering ER. Quality assessment of immunological marker analysis and the immunological diagnosis in leukaemia and lymphoma: A multi-centre study. Dutch Cooperative Study Group on Immunophenotyping of Leukaemias and Lymphomas (SIHON). Br J Haematol 1992; 80: 458-65.
51. Matutes E, Morilla R, Farahat N, et al. Definition of acute biphenotypic leukemia. Haematologica 1997; 82: 64-6.
52. Vidriales MB, San-Miguel JF, Orfao A, Coustan-Smith E, Campana D. Minimal residual disease monitoring by flow cytometry. Best Pract Res Clin Haematol 2003; 16: 599-612.
53. Stelzer GT, Marti G, Hurley A, McCoy P Jr, Lovett EJ, Schwartz A. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Standardization and validation of laboratory procedures. Cytometry 1997; 30: 214-230.
54. Stewart CC, Behm FG, Carey JL, et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations. Cytometry 1997; 30: 231-5.
55. Borowitz MJ, Bray R, Gascoyne R, et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data analysis and interpretation. Cytometry 1997; 30: 236-44.
56. Braylan RC, Atwater SK, Diamond L, et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Data reporting. Cytometry 1997; 30: 245-8.
57. Davis BH, Foucar K, Szczarkowski W, et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Medical indications. Cytometry 1997; 30: 249-63.
58. Kluin-Nelemans JC, van Wering ER, van'T Veer MB, et al. Pitfalls in the immuno-phenotyping of leukaemia and leukaemic lymphomas: Survey of 9 years of quality control in The Netherlands. Dutch Cooperative Study Group on Immuno-phenotyping of Haematological Malignancies (SIHON). Br J Haematol 1996; 95: 692-9.
59. Kluin-Nelemans J, Van Wering E, Van Der Schoot C, et al. for the Dutch Co-operative Study Group on Immunophenotyping of Haematological Malignancies (SIHON). SIHON-SCORE: A scoring system for external quality control of leukaemia/lymphoma immuno-phenotyping measuring all analytical phases of laboratory performance. Br J Haematol 2001; 112: 337-43.
60. Gratama JW, Van Beers W, Eidhof H, et al. Externe kwaliteitsbewaking van flowcyto-metrische immuno-fenotypering. In: Van Lochem EG, Van der Velden VHJ, Hooijkaas H, Van Dongen JJM, eds. Nieuwe diagnostische toepassingen van flowcytometrie. Rotterdam, Afdeling Immunologie, Erasmus MC; 2003: pp. 223-33.
61. Van Veen JJ, Reilly JT, Richards SJ, et al. Diagnosis of plasma cell leukaemia: Findings of the UK NEQAS for Leucocyte Immunophenotyping scheme. Clin Lab Haematol 2004; 26: 37-42.
62. Del Vecchio L, Brando B, Lanza F, et al. Recommended reporting format for flow cytometry diagnosis of acute leukemia. Haematologica 2004; 89: 594-8.